Investment Rating - The investment rating for the company is "Buy" and is maintained [8] Core Views - The company is projected to achieve operating revenue of 189.5 billion yuan in 2025, representing a year-on-year growth of 1.97%. The net profit attributable to shareholders is expected to be 6.436 billion yuan, an increase of 13.15% year-on-year, while the net profit after deducting non-recurring items is forecasted to be 6.090 billion yuan, up 10.44% year-on-year [5][11] Financial Performance - The engineering business is expected to generate total revenue of 178.133 billion yuan in 2025, with a year-on-year growth of 1.59%, accounting for 94% of total revenue, a slight decrease of 0.27 percentage points. The industrial business is anticipated to contribute significantly, with revenue of 9.754 billion yuan, a year-on-year increase of 11.47%, representing 5.13% of total revenue, an increase of 0.44 percentage points year-on-year [11] - The gross margin is projected to improve significantly, reaching 10.71% in 2025, an increase of 0.60 percentage points year-on-year. The gross margins for engineering and industrial segments are expected to rise by 0.58 and 1.16 percentage points, respectively [11] - The cash collection ratio is expected to improve to 105.34%, a significant increase of 13.63 percentage points year-on-year, although the net cash flow from operating activities is projected to be only 1.443 billion yuan, a decrease of 7.279 billion yuan year-on-year [11] - The company achieved all incentive targets, with a net profit of 6.090 billion yuan, meeting the target of a 15% growth from the 2021 performance base [11] Future Outlook - The company is expected to see net profits of 6.885 billion yuan, 7.623 billion yuan, and 8.401 billion yuan for the years 2026, 2027, and 2028, respectively, corresponding to price-to-earnings ratios of 8.10, 7.31, and 6.64 [11]
中国化学(601117):联合研究|公司点评|中国化学(601117.SH):业绩高速增长,毛利率显著提升